hopTo (HPTO) 10-K 31 Mar 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Cover [Abstract]
Entity Registrant Name	hopTo Inc.
Entity Central Index Key	0001021435
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 2,111,134
Entity Common Stock, Shares Outstanding		18,850,675
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 4,375,300	$ 1,541,900
Accounts receivable, net	417,300	271,200
Prepaid expenses and other current assets	48,500	59,000
Total current assets	4,841,100	1,872,100
Property and equipment, net
Other assets	17,800	17,800
Total assets	4,858,900	1,889,900
Current liabilities
Accounts payable	251,000	271,900
Accrued expenses	82,000	106,000
Accrued wages	141,600	136,400
Deferred revenue	1,084,900	1,256,000
Total current liabilities	1,559,500	1,770,300
Long-term liabilites
Deferred revenue	383,000	529,500
Total liabilities	1,942,500	2,299,800
Commitments and contingencies
Stockholders' equity (deficit)
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2020 or 2019
Common stock, $0.0001 par value, 195,000,000 shares authorized, 18,850,675 and 9,834,866 shares issued and outstanding as of December 31, 2020 and 2019, respectively	1,900	1,000
Additional paid-in capital	82,155,200	79,523,500
Accumulated deficit	(79,240,700)	(79,934,400)
Total stockholders' equity (deficit)	2,916,400	(409,900)
Total liabilities and stockholders' equity (deficit)	$ 4,858,900	$ 1,889,900

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	195,000,000	195,000,000
Common stock, shares issued	18,850,675	9,834,866
Common stock, shares outstanding	18,850,675	9,834,866

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Total Revenue	$ 3,644,000	$ 3,530,100
Cost of Revenue:
Total cost of revenue	155,000	149,800
Gross profit	3,489,000	3,380,300
Operating expenses:
Selling and marketing	509,300	442,400
General and administrative	900,500	864,700
Research and development	1,430,100	1,533,000
Total operating expenses	2,839,900	2,840,100
Income from operations	649,100	540,200
Other income:
Other income	44,600	14,100
Income before provision for income taxes	693,700	554,300
Provision for income taxes
Net income	$ 693,700	$ 554,300
Net income per share, basic	$ 0.05	$ 0.06
Net income per share, diluted	$ 0.05	$ 0.05
Weighted average number of common shares outstanding
Basic	13,874,699	9,821,177
Diluted	14,117,850	10,287,183
Software License [Member]
Revenues:
Total Revenue	$ 853,300	$ 952,600
Software Service Fees [Member]
Revenues:
Total Revenue	2,474,500	2,483,600
Other [Member]
Revenues:
Total Revenue	316,200	93,900
Software Service Costs [Member]
Cost of Revenue:
Total cost of revenue	52,700	52,700
Software Product Costs [Member]
Cost of Revenue:
Total cost of revenue	$ 102,300	$ 97,100

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2018	$ 1,000	$ 79,298,200	$ (80,488,700)	$ (1,189,500)
Beginning balance, shares at Dec. 31, 2018	9,804,400
Contributed services		225,100		225,100
Cashless exercise of warrants		300		300
Cashless exercise of warrants, shares	30,466
Other rounding		(100)		(100)
Shares issued for accrued liabilities
Shares issued for accrued liabilities, shares
Proceeds from rights offering
Proceeds from rights offering, shares
Issuance cost for rights offering
Net Income (loss)			554,300	554,300
Ending balance at Dec. 31, 2019	$ 1,000	79,523,500	(79,934,400)	(409,900)
Ending balance, shares at Dec. 31, 2019	9,834,866
Contributed services		112,400		112,400
Cashless exercise of warrants
Cashless exercise of warrants, shares	229,141
Other rounding
Shares issued for accrued liabilities		39,600
Shares issued for accrued liabilities, shares	120,000
Proceeds from rights offering	$ 900	2,599,100		2,600,000
Proceeds from rights offering, shares	8,666,668
Issuance cost for rights offering		(119,400)		(119,400)
Net Income (loss)			693,700	693,700
Ending balance at Dec. 31, 2020	$ 1,900	$ 82,155,200	$ (79,240,700)	$ 2,916,400
Ending balance, shares at Dec. 31, 2020	18,850,675

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net income	$ 693,700	$ 554,300
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		400
Contributed services	112,400	225,100
Changes in allowance for doubtful accounts	(1,400)	3,700
Changes in operating assets and liabilities:
Accounts receivable	(144,700)	(64,100)
Prepaid expenses and other current assets	10,500	20,000
Accounts payable	(20,900)	(46,800)
Accrued expenses	15,600	(15,600)
Accrued wages	5,200	(9,400)
Deposit liability		(12,100)
Deferred revenue	(317,600)	(6,300)
Net cash provided by operating activities	352,800	649,200
Cash flows from financing activities
Proceeds from rights offering	2,600,000
Issuance cost for rights offering	(119,400)
Proceeds from exercise of warrants		300
Other rounding		(100)
Net cash provided by financing activities	2,480,600	200
Net change in cash	2,833,400	649,400
Cash, beginning of the year	1,541,900	892,500
Cash, end of the year	$ 4,375,300	$ 1,541,900

Organization

Organization	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization hopTo Inc., a Delaware corporation, through its wholly-owned subsidiary GraphOn Corporation (collectively, “we”, “us,” “our” or the “Company”) are developers of application publishing software which includes application virtualization software and cloud computing software for multiple computer operating systems including Windows, UNIX and several Linux-based variants. The Company sells a family of products under the brand name GO-Global, which is a software application publishing business and is the Company’s sole revenue source at this time. GO-Global is an application access solution for use and/or resale by independent software vendors, corporate enterprises, governmental and educational institutions, and others, who wish to take advantage of cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are deploying secure, private cloud environments.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Basis of Presentation The consolidated financial statements include the accounts of hopTo Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated upon consolidation. The consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to financial information and the rules and regulations promulgated by the Securities and Exchange Commission (the “SEC”). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Amounts could materially change in the future. These estimates include the allowance for doubtful accounts and contributed services. While the Company believes that such estimates are fair, actual results could differ materially from those estimates. Liquidity The Company has incurred significant net losses since inception. As of December 31, 2020, we had working capital of $3,281,600, which includes deferred revenue of $1,084,900. Our ability to continue to generate net income and positive cash flows from operations is dependent on our ability to continue to generate revenue from our legacy GO-Global business, which in turn is subject to a variety of risks. The Company believes its current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet its working capital requirements for at least one year from the date of the issuance of the accompanying financial statements. The Company continues to control its cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term to invest in revenue growth. Based on current internal projections, the Company believes it has and/or will generate sufficient cash for its operational needs, for at least one year from the date of issuance of the accompanying financial statements. Management is focused on growing the Company’s existing product offering, as well as its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company may need to raise additional capital in the future. However, the Company cannot assure that it will be able to raise additional capital on acceptable terms, or at all. Revenue Recognition The Company markets and licenses its products indirectly through channel distributors, value-added resellers, independent software vendors (“ISVs”), hosting service providers, corporate enterprises, governmental and educational institutions and others. Our product licenses are perpetual. We also separately sell intellectual property licenses, maintenance contracts, which are comprised of license updates and customer service access, as well as other products and services. There are no rights of return granted to purchasers of the Company’s software products. The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” Revenues under ASC 606 are recognized when the promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. For the years ended December 31, 2020 and 2019, revenue recognition was determined by ● identifying the contract, or contracts, with a customer; ● identifying the performance obligations in each contract; ● determine the transaction price; ● allocating the transaction price to the performance obligations in each contract; and ● recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services When control of the promised products and services are transferred to our customers, we recognize revenue in the amount that reflects the consideration we expect to receive in exchange for these products and services. Product Sales All of our licenses are delivered to the customer electronically. The Company sends the license key to the customer to download the related software from Company portal. We recognize revenue upon delivery of these licenses. For stocking resellers who purchase licenses through inventory stocking orders with the intent to resell to an end-user, revenue is recognized when the resellers’ accounts have been credited, at their discretion, for the number of licenses purchased. Maintenance revenue was also recognized from service contracts ratably over the related contract period. The Company operates in one reportable segment. The Company’s product sales by geographic area are presented in Note 6. Cash and Cash Equivalents The Company considers all highly liquid holdings with maturities of three months or less at the time of purchase to be cash equivalents. The Company had no cash equivalents as of December 31, 2020 or 2019. Allowance for Doubtful Accounts We maintain an allowance for doubtful accounts that reflects our best estimate of potentially uncollectible trade receivables. The allowance is based on assessments of the collectability of specific customer accounts and the general aging and size of the accounts receivable. We regularly review the adequacy of our allowance for doubtful accounts by considering such factors as historical experience, credit worthiness, and current economic conditions that may affect a customer’s ability to pay. We specifically reserve for those accounts deemed uncollectible. We also establish, and adjust, a general allowance for doubtful accounts based on our review of the aging and size of our accounts receivable. As of December 31, 2020 and 2019, the allowance for doubtful accounts totaled $5,900 and $7,300, respectively. Long-Lived Assets Long-lived assets are assessed for possible impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable, whenever we have committed to a plan to dispose of the assets or, at a minimum, annually. Typically, for long-lived assets to be held and used, measurement of an impairment loss is based on the fair value of such assets, with fair value being determined based on appraisals, current market value, comparable sales value, and discounted future cash flows, among other variables, as appropriate. Assets to be held and used (which assets are affected by an impairment loss) are depreciated or amortized at their new carrying amount over their remaining estimated life; assets to be sold or otherwise disposed of are not subject to further depreciation or amortization. No such impairment charge was recorded during the years ended December 31, 2020 or 2019. Property and Equipment Property and equipment are recorded at historical cost and depreciated on a straight-line basis over their estimated useful lives ranging from three to seven years. All of our existing property and equipment are fully depreciated. Software Development Costs Under the criteria set forth in Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) 985-20, “Costs of Software to be Sold, Leased or Marketed,” Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and trade receivables. The Company places its cash with high quality financial institutions and, by policy, limits the amount of credit exposure to any one financial institution. As of December 31, 2020, the Company had approximately $4,125,300 of cash with financial institutions in excess of FDIC insurance limits. For the year ended December 31, 2020, we had one reseller that represented more than 14.5% of sales and one reseller that represented 44.7% of accounts receivable. For the year ended December 31, 2019, we had two resellers that represented 14.0% and 14.3% of sales, respectively and one reseller that represented 17.9% of accounts receivable. For the purposes of this description, “sales” refers to the dollar value of orders received from these customers and partners in the period indicated. The sales values do not necessarily equal recognized revenue for these periods due to our revenue recognition policies which require deferral of revenue associated with prepaid software service fees. The loss of one of these resellers would not have a material impact as the Company could take over the end customer relationship. Income Taxes The Company accounts for income taxes in accordance with ASC 740, “Income Taxes,” using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Basic and Diluted Earnings Per Share In accordance with ASC 260, “Earnings Per Share,” the basic income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average common shares outstanding during the period. Diluted income (loss) per share reflect per share amounts that would have resulted if diluted potential common stock had been converted to common stock. Dilutive common share equivalents as of December 31, 2020 and 2019, representing 248,216 and 481,335 outstanding in-the-money warrants respectively, were included in the computation of diluted net income (loss) per share using the Treasury Stock Method. During the year ended December 31, 2020 and 2019, the Company had total common stock equivalents of 93,076 and 106,077 shares, respectively, which excluded from the computation of net income per share because they are anti-dilutive. Stock-Based Compensation The Company applies the fair value recognition provisions of FASB ASC 718-10, “ Compensation – Stock Compensation. Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses. The carrying amount of these financial instruments approximates fair value due to the nature of the accounts and their short-term maturities. The fair value of the Company’s warrants are determined in accordance with FASB ASC 820, “Fair Value Measurement,” ● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. ● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation. We do not have level 2 and 3 liabilities or assets.

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued Expenses	3. Accrued Expenses Accrued expenses as of December 31, 2020 and 2019 consisted of the following: 2020 2019 Consulting services $ 6,200 $ 2,000 Board of director fees 46,000 85,600 Legal fees 3,100 6,400 Reimbursements 20,300 - Other 6,400 12,000 $ 82,000 $ 106,000

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	4. Stockholders’ Equity Stock-Based Compensation Plans In November 2012, the Company’s 2012 Equity Incentive Plan (the “12 Plan”) was approved by the stockholders. Pursuant to the terms of the 12 Plan, stock options, stock appreciation rights, restricted stock and restricted stock units (sometimes referred to individually or collectively as “awards”) may be granted to officers and other employees, non-employee directors and independent consultants and advisors who render services to the Company. The Company is authorized to issue options to purchase up to 643,797 shares of common stock, stock appreciation rights, or restricted stock in accordance with the terms of the 12 Plan. In the case of a restricted stock award, the entire number of shares subject to such award would be issued at the time of the grant and subject to vesting provisions based on time or other conditions specified by the Board or an authorized committee of the Board. For awards based on time, should the grantee’s service to the Company end before full vesting occurred, all unvested shares would be forfeited and returned to the Company. In the case of awards granted with vesting provisions based on specific performance conditions, if those conditions were not met, then all shares would be forfeited and returned to the Company. Until forfeited, all shares issued under a restricted stock award would be considered outstanding for dividend, voting and other purposes. Under the 12 Plan, the exercise price of non-qualified stock options granted is to be no less than 100% of the fair market value of the Company’s common stock on the date the option is granted. The exercise price of incentive stock options granted is to be no less than 100% of the fair market value of the Company’s common stock on the date the option is granted provided, however, that if the recipient of the incentive stock option owns greater than 10% of the voting power of all shares of the Company’s capital stock then the exercise price will be no less than 110% of the fair market value of the Company’s common stock on the date the option is granted. The purchase price of the restricted stock issued under the 12 Plan shall also not be less than 100% of the fair market value of the Company’s common stock on the date the restricted stock is granted. All options granted under the 12 Plan are immediately exercisable by the optionee; however, there is a vesting period for the options. The options (and the shares of common stock issuable upon exercise of such options) vest, ratably, over a 33-month period; however, no options (and the underlying shares of common stock) vest until after three months from the date of the option grant. The exercise price is immediately due upon exercise of the option. The maximum term of options issued under the 12 Plan is ten years. Shares issued upon exercise of options are subject to the Company’s repurchase, which right lapses as the shares vest. The 12 Plan will terminate no later than November 7, 2022. As of December 31, 2020, 411,593 shares of common stock remained available for issuance under the 12 Plan. The following table summarizes the stock option activity for the year ended December 31, 2020 and 2019. Weighted- Average Weighted- Remaining Average Contractual Exercise Life Options Price (Years) Outstanding at December 31, 2018 117,675 $ 2.57 2.28 Granted - Forfeited/cancelled (11,598 ) Outstanding at December 31, 2019 106,077 $ 2.77 1.53 Granted - Forfeited/cancelled (13,001 ) Exercised - Outstanding at December 31, 2020 93,076 $ 3.03 0.74 Vested and expected to vest at December 31, 2020 93,076 $ 3.03 0.74 Exercisable at December 31, 2020 93,076 $ 3.03 0.74 The following table summarizes information about stock options outstanding and exercisable as of December 31, 2020. Options Outstanding Options Exercisable Weighted- Weighted- Range of Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 0.75 - 1.00 14,526 0.03 $ 0.75 14,526 $ 0.75 1.79 - 4.00 63,684 0.87 3.21 63,684 3.21 4.20 - 6.68 14,866 0.89 4.46 14,866 4.46 93,076 93,076 Warrants During the year ended December 31, 2020, the Company issued 233,119 shares of common stock for the exercise of 233,119 warrants. During the year ended December 31, 2019, the Company issued 30,466 shares of common stock for the exercise of 30,466 warrants. As of December 31, 2020, and 2019, the Company had 248,216 and 481,335 warrants outstanding, respectively. The warrants outstanding at December 31, 2020 are all exercisable at $0.01 and have an expiration date of May 20, 2023. Rights Offering See Note 8. The following summarized changes in the number of warrants outstanding for the year ended December 31, 2020 and 2019. Warrants Outstanding at December 31, 2018 622,912 Granted - Forfeited/cancelled (111,111 ) Exercised (30,466 ) Outstanding at December 31, 2019 481,335 Exercised (233,119 ) Outstanding at December 31, 2020 248,216

Sales by Geographical Location

Sales by Geographical Location	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Sales by Geographical Location	5. Sales by Geographical Location Revenue by country for the year ended December 31, 2020 and 2019 was as follows. For the Year Ended December 31, 2020 December 31, 2019 Revenue by Country United States $ 1,276,700 $ 1,133,400 Brazil 1,117,300 580,800 Japan 338,300 410,000 The Netherlands 307,700 445,100 Other Countries 604,000 960,800 Total $ 3,644,000 $ 3,530,100

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes The components of the provision (benefit) for income taxes for the years ended December 31, 2020 and 2019 consisted of the following: 2020 2019 Current Federal $ — $ — State — — Foreign — — $ — $ — Deferred Federal $ — $ — State — — Foreign — — — — Total $ — $ — The following table summarizes the differences between income tax expense and the amount computed applying the federal income tax rate of 21% for the years ended December 31, 2020 and 2019, respectively: 2020 2019 Federal income tax (benefit) at statutory rate $ 145,700 $ 116,400 State income tax (benefit) at statutory rate 16,400 13,900 SBC – NQ cancellations (2,700 ) (2,700 ) Change in valuation allowance (2,763,100 ) (284,900 ) Meals and entertainment (50%) 200 1,000 Adjustments and NOL expirations 2,603,500 103,400 Contributed services — 52,900 Other items — — Provision (benefit) for income tax $ — $ — Deferred income taxes and benefits result from temporary timing differences in the recognition of certain expense and income items for tax and financial reporting purposes. The following table sets forth those differences as of December 31, 2020 and 2019: 2020 2019 Net operating loss carryforwards $ 11,031,900 $ 13,702,300 Tax credit carryforwards 977,500 977,500 Compensation expense – non-qualified stock options 65,800 69,000 Deferred revenue and maintenance service contracts 343,100 419,800 Depreciation, amortization, and capitalized software — — Reserves and other 53,300 58,200 Total deferred tax assets 12,471,600 15,226,800 Deferred tax liability – depreciation, amortization and capitalized software — — Net deferred tax asset 12,471,600 15,226,800 Valuation allowance (12,471,600 ) (15,226,800 ) Net deferred tax asset $ — $ — For financial reporting purposes, with the exception of the years ended December 31, 2020 and 2019, the Company has incurred a loss in each year since inception. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its net deferred tax assets at December 31, 2020 and 2019. The net change in the valuation allowance was decreased by $2,755,000 and $276,000 for the years ended December 31, 2020 and 2019, respectively. At December 31, 2020, the Company had approximately $50.3 million of federal net operating loss carryforwards and approximately $6.8 million of California state net operating loss carryforwards available to reduce future taxable income. The federal loss carryforwards began to expire in 2021 and the California state loss carry forwards begin to expire in 2028. Under the Tax Reform Act of 1986, the amount of benefits from net operating loss carryforwards may be impaired or limited if the Company incurs a cumulative ownership change of more than 50%, as defined, over a three-year period. At December 31, 2020, the Company had approximately $1.0 million of federal research and development tax credits that began to expire in 2018.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. Commitments and Contingencies Leases Our headquarters in Concord, NH is a month-to-month rent basis, requiring a six-month notice from the lessor to terminate. Rent on the corporate headquarters continues at $4,000 per month. Rent expense aggregated approximately $48,000 for both years ended December 31, 2020 and 2019. Contingencies Under its Amended and Restated Certificate of Incorporation and Second Amended and Restated Bylaws and certain agreements with officers and directors, the Company has agreed to indemnify its officers and directors for certain events or occurrences arising as a result of the officer’s or director’s serving in such capacity. Generally, the term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is limited as the Company currently has a directors and officers liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements is minimal and has no liabilities recorded for these agreements as of December 31, 2020. The Company enters into indemnification provisions under (i) its agreements with other companies in its ordinary course of business, including contractors and customers and (ii) its agreements with investors. Under these provisions, the Company generally indemnifies and holds harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Company’s activities or, in some cases, as a result of the indemnified party’s activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by the Company with regard to intellectual property rights, and often survive termination of the underlying agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes the estimated fair value of these agreements is minimal. Accordingly, the Company has no liabilities recorded for these agreements as of December 31, 2020. The Company’s software license agreements also generally include a performance guarantee that the Company’s software products will operate substantially as described in the applicable program documentation for a period of 90 days after delivery. The Company also generally warrants that services that the Company performs will be provided in a manner consistent with reasonably applicable industry standards. To date, the Company has not incurred any material costs associated with these warranties and has no liabilities recorded for these agreements as of December 31, 2020. Profit Sharing Plans The Company has adopted a 401(k) plan to provide retirement benefits for employees under which the Company makes discretionary matching contributions. During the years ended December 31, 2020 and 2019, the Company contributed a total of $16,000 and $14,100, respectively.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	8. Related Party Transactions On September 30, 2020, the Company entered into an executive employment agreement with Jonathon R. Skeels, the Company’s Chief Executive Officer and Interim Chief Financial Officer, effective as of July 1, 2020. Pursuant to the Agreement, Mr. Skeels is entitled to receive a base salary of $200,000 per year and other compensation to be determined from time to time by the Company in its sole discretion. The Agreement also entitles Mr. Skeels to participate in the Company’s employee benefit plans and be reimbursed for expenses incurred in connection with his service to the Company. If Mr. Skeels’ employment is terminated without cause (as defined in the Agreement) the Company will, against the receipt of a mutual release, pay Mr. Skeels an amount equal to 12 months of his annual base salary and pay the premiums for continuation of Mr. Skeels and his family’s health insurance for up to 12 months following his termination. Mr. Skeels has served as the Company’s Chief Executive Officer and Interim Chief Financial Officer since September 2018, however, previously did not receive a salary or other forms of compensation. During the years ended December 31, 2020 and 2019, the Company recorded an expense and contributed capital of approximately $112,400, and $225,100, respectively for contributed services based on the estimated market rate for these services. Mr. Skeels controls an entity named Novelty Capital Partners LP that is a significant shareholder in the Company. On January 31, 2020, we entered into the Backstop Agreement (the “Backstop Agreement”) with a consortium of accredited investors, including all of our directors and led by Novelty Capital Partners LP, pursuant to which such investors agreed to purchase in a private placement, at $0.30 per share, up to 2.41 million of shares of our common stock. The consummation of the investment pursuant to the Backstop Agreement was conditioned on the closing of our subscription rights offering to all of our stockholders (the “Rights Offering”). The Rights Offering expired on March 31, 2020, and we consummated the Backstop Agreement transactions on August 13, 2020. At closing of the Rights Offering, we received net proceeds of $480,200 in exchange for 1.6 million shares of common stock. Pursuant to the Backstop Agreement, we received gross proceeds of $2.12 million in exchange for the issuance of 7.0 million restricted shares of common stock.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements include the accounts of hopTo Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated upon consolidation. The consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) applicable to financial information and the rules and regulations promulgated by the Securities and Exchange Commission (the “SEC”).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Amounts could materially change in the future. These estimates include the allowance for doubtful accounts and contributed services. While the Company believes that such estimates are fair, actual results could differ materially from those estimates.
Liquidity	Liquidity The Company has incurred significant net losses since inception. As of December 31, 2020, we had working capital of $3,281,600, which includes deferred revenue of $1,084,900. Our ability to continue to generate net income and positive cash flows from operations is dependent on our ability to continue to generate revenue from our legacy GO-Global business, which in turn is subject to a variety of risks. The Company believes its current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet its working capital requirements for at least one year from the date of the issuance of the accompanying financial statements. The Company continues to control its cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term to invest in revenue growth. Based on current internal projections, the Company believes it has and/or will generate sufficient cash for its operational needs, for at least one year from the date of issuance of the accompanying financial statements. Management is focused on growing the Company’s existing product offering, as well as its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company may need to raise additional capital in the future. However, the Company cannot assure that it will be able to raise additional capital on acceptable terms, or at all.
Revenue Recognition	Revenue Recognition The Company markets and licenses its products indirectly through channel distributors, value-added resellers, independent software vendors (“ISVs”), hosting service providers, corporate enterprises, governmental and educational institutions and others. Our product licenses are perpetual. We also separately sell intellectual property licenses, maintenance contracts, which are comprised of license updates and customer service access, as well as other products and services. There are no rights of return granted to purchasers of the Company’s software products. The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” Revenues under ASC 606 are recognized when the promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. For the years ended December 31, 2020 and 2019, revenue recognition was determined by ● identifying the contract, or contracts, with a customer; ● identifying the performance obligations in each contract; ● determine the transaction price; ● allocating the transaction price to the performance obligations in each contract; and ● recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services When control of the promised products and services are transferred to our customers, we recognize revenue in the amount that reflects the consideration we expect to receive in exchange for these products and services. Product Sales All of our licenses are delivered to the customer electronically. The Company sends the license key to the customer to download the related software from Company portal. We recognize revenue upon delivery of these licenses. For stocking resellers who purchase licenses through inventory stocking orders with the intent to resell to an end-user, revenue is recognized when the resellers’ accounts have been credited, at their discretion, for the number of licenses purchased. Maintenance revenue was also recognized from service contracts ratably over the related contract period. The Company operates in one reportable segment. The Company’s product sales by geographic area are presented in Note 6.
Cash and Cash equivalents	Cash and Cash Equivalents The Company considers all highly liquid holdings with maturities of three months or less at the time of purchase to be cash equivalents. The Company had no cash equivalents as of December 31, 2020 or 2019.
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts We maintain an allowance for doubtful accounts that reflects our best estimate of potentially uncollectible trade receivables. The allowance is based on assessments of the collectability of specific customer accounts and the general aging and size of the accounts receivable. We regularly review the adequacy of our allowance for doubtful accounts by considering such factors as historical experience, credit worthiness, and current economic conditions that may affect a customer’s ability to pay. We specifically reserve for those accounts deemed uncollectible. We also establish, and adjust, a general allowance for doubtful accounts based on our review of the aging and size of our accounts receivable. As of December 31, 2020 and 2019, the allowance for doubtful accounts totaled $5,900 and $7,300, respectively.
Long-Lived Assets	Long-Lived Assets Long-lived assets are assessed for possible impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable, whenever we have committed to a plan to dispose of the assets or, at a minimum, annually. Typically, for long-lived assets to be held and used, measurement of an impairment loss is based on the fair value of such assets, with fair value being determined based on appraisals, current market value, comparable sales value, and discounted future cash flows, among other variables, as appropriate. Assets to be held and used (which assets are affected by an impairment loss) are depreciated or amortized at their new carrying amount over their remaining estimated life; assets to be sold or otherwise disposed of are not subject to further depreciation or amortization. No such impairment charge was recorded during the years ended December 31, 2020 or 2019.
Property and Equipment	Property and Equipment Property and equipment are recorded at historical cost and depreciated on a straight-line basis over their estimated useful lives ranging from three to seven years. All of our existing property and equipment are fully depreciated.
Software Development Costs	Software Development Costs Under the criteria set forth in Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) 985-20, “Costs of Software to be Sold, Leased or Marketed,”
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and trade receivables. The Company places its cash with high quality financial institutions and, by policy, limits the amount of credit exposure to any one financial institution. As of December 31, 2020, the Company had approximately $4,125,300 of cash with financial institutions in excess of FDIC insurance limits. For the year ended December 31, 2020, we had one reseller that represented more than 14.5% of sales and one reseller that represented 44.7% of accounts receivable. For the year ended December 31, 2019, we had two resellers that represented 14.0% and 14.3% of sales, respectively and one reseller that represented 17.9% of accounts receivable. For the purposes of this description, “sales” refers to the dollar value of orders received from these customers and partners in the period indicated. The sales values do not necessarily equal recognized revenue for these periods due to our revenue recognition policies which require deferral of revenue associated with prepaid software service fees. The loss of one of these resellers would not have a material impact as the Company could take over the end customer relationship.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC 740, “Income Taxes,” using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share In accordance with ASC 260, “Earnings Per Share,” the basic income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average common shares outstanding during the period. Diluted income (loss) per share reflect per share amounts that would have resulted if diluted potential common stock had been converted to common stock. Dilutive common share equivalents as of December 31, 2020 and 2019, representing 248,216 and 481,335 outstanding in-the-money warrants respectively, were included in the computation of diluted net income (loss) per share using the Treasury Stock Method. During the year ended December 31, 2020 and 2019, the Company had total common stock equivalents of 93,076 and 106,077 shares, respectively, which excluded from the computation of net income per share because they are anti-dilutive.
Stock-Based Compensation	Stock-Based Compensation The Company applies the fair value recognition provisions of FASB ASC 718-10, “ Compensation – Stock Compensation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses. The carrying amount of these financial instruments approximates fair value due to the nature of the accounts and their short-term maturities. The fair value of the Company’s warrants are determined in accordance with FASB ASC 820, “Fair Value Measurement,” ● Level 1: Defined as observable inputs, such as quoted (unadjusted) prices in active markets for identical assets or liabilities. ● Level 2: Defined as observable inputs other than quoted prices included in Level 1. This includes quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3: Defined as unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation. We do not have level 2 and 3 liabilities or assets.

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses as of December 31, 2020 and 2019 consisted of the following: 2020 2019 Consulting services $ 6,200 $ 2,000 Board of director fees 46,000 85,600 Legal fees 3,100 6,400 Reimbursements 20,300 - Other 6,400 12,000 $ 82,000 $ 106,000

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the stock option activity for the year ended December 31, 2020 and 2019. Weighted- Average Weighted- Remaining Average Contractual Exercise Life Options Price (Years) Outstanding at December 31, 2018 117,675 $ 2.57 2.28 Granted - Forfeited/cancelled (11,598 ) Outstanding at December 31, 2019 106,077 $ 2.77 1.53 Granted - Forfeited/cancelled (13,001 ) Exercised - Outstanding at December 31, 2020 93,076 $ 3.03 0.74 Vested and expected to vest at December 31, 2020 93,076 $ 3.03 0.74 Exercisable at December 31, 2020 93,076 $ 3.03 0.74
Schedule of Share-based Compensation, Shares Authorized Under Stock Option Plans, by Exercise Price Range	The following table summarizes information about stock options outstanding and exercisable as of December 31, 2020. Options Outstanding Options Exercisable Weighted- Weighted- Range of Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 0.75 - 1.00 14,526 0.03 $ 0.75 14,526 $ 0.75 1.79 - 4.00 63,684 0.87 3.21 63,684 3.21 4.20 - 6.68 14,866 0.89 4.46 14,866 4.46 93,076 93,076
Schedule of Warrants Outstanding	The following summarized changes in the number of warrants outstanding for the year ended December 31, 2020 and 2019. Warrants Outstanding at December 31, 2018 622,912 Granted - Forfeited/cancelled (111,111 ) Exercised (30,466 ) Outstanding at December 31, 2019 481,335 Exercised (233,119 ) Outstanding at December 31, 2020 248,216

Sales by Geographical Location

Sales by Geographical Location (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Schedule of Revenue by Country	Revenue by country for the year ended December 31, 2020 and 2019 was as follows. For the Year Ended December 31, 2020 December 31, 2019 Revenue by Country United States $ 1,276,700 $ 1,133,400 Brazil 1,117,300 580,800 Japan 338,300 410,000 The Netherlands 307,700 445,100 Other Countries 604,000 960,800 Total $ 3,644,000 $ 3,530,100

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The components of the provision (benefit) for income taxes for the years ended December 31, 2020 and 2019 consisted of the following: 2020 2019 Current Federal $ — $ — State — — Foreign — — $ — $ — Deferred Federal $ — $ — State — — Foreign — — — — Total $ — $ —
Schedule of Effective Income Tax Rate Reconciliation	The following table summarizes the differences between income tax expense and the amount computed applying the federal income tax rate of 21% for the years ended December 31, 2020 and 2019, respectively: 2020 2019 Federal income tax (benefit) at statutory rate $ 145,700 $ 116,400 State income tax (benefit) at statutory rate 16,400 13,900 SBC – NQ cancellations (2,700 ) (2,700 ) Change in valuation allowance (2,763,100 ) (284,900 ) Meals and entertainment (50%) 200 1,000 Adjustments and NOL expirations 2,603,500 103,400 Contributed services — 52,900 Other items — — Provision (benefit) for income tax $ — $ —
Schedule of Deferred Tax Assets and Liabilities	The following table sets forth those differences as of December 31, 2020 and 2019: 2020 2019 Net operating loss carryforwards $ 11,031,900 $ 13,702,300 Tax credit carryforwards 977,500 977,500 Compensation expense – non-qualified stock options 65,800 69,000 Deferred revenue and maintenance service contracts 343,100 419,800 Depreciation, amortization, and capitalized software — — Reserves and other 53,300 58,200 Total deferred tax assets 12,471,600 15,226,800 Deferred tax liability – depreciation, amortization and capitalized software — — Net deferred tax asset 12,471,600 15,226,800 Valuation allowance (12,471,600 ) (15,226,800 ) Net deferred tax asset $ — $ —

Significant Accounting Polici_3

Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Working capital	$ 3,281,600
Deferred revenue	1,084,900	$ 1,256,000
Cash equivalents
Allowance for doubtful accounts	5,900	$ 7,300
Cash, FDIC insured amount	$ 4,125,300
Number of common shares equivalents of outstanding in money warrants	248,216	481,335
Shares of common stock equivalents excluded from computation of diluted earnings per share	93,076	106,077
Sales [Member] | Reseller One [Member]
Concentration of credit risk percentage		14.00%
Sales [Member] | Reseller Two [Member]
Concentration of credit risk percentage		14.30%
Accounts Receivable [Member] | Reseller One [Member]
Concentration of credit risk percentage	44.70%	17.90%
Minimum [Member]
Property, plant and equipment, useful life	3 years
Minimum [Member] | Sales [Member] | Reseller One [Member]
Concentration of credit risk percentage	14.50%
Maximum [Member]
Property, plant and equipment, useful life	7 years

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Payables and Accruals [Abstract]
Consulting services	$ 6,200	$ 2,000
Board of director fees	46,000	85,600
Legal fees	3,100	6,400
Reimbursements	20,300
Other	6,400	12,000
Accrued expenses	$ 82,000	$ 106,000

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Jan. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Proceeds from offering		$ 2,600,000
Number of common stock issued for exercise of warrants		233,119	30,466
Warrants outstanding		248,216	481,335
Warrants outstanding exercisable price		$ 0.01
Warrants expiration date		May 20, 2023
Backstop Agreement [Member]
Number of restricted shares of common stock, value		$ 2,120,000
Number of restricted shares of common stock		7,000,000
Backstop Agreement [Member] | Accredited Investors [Member] | Novelty Capital Partners LP [Member]
Shares issued purchase price, per share	$ 0.30
Backstop Agreement [Member] | Rights Offering [Member] | Novelty Capital Partners LP [Member]
Debt instrument maturity date	Mar. 31, 2020
Rights Offering [Member]
Number of shares issued in private placement		1,600,000
Proceeds from offering		$ 480,200
Maximum [Member] | Backstop Agreement [Member] | Accredited Investors [Member] | Novelty Capital Partners LP [Member]
Number of shares issued in private placement	2,410,000
2012 Equity Incentive Plan [Member]
Share-based compensation arrangement by share-based payment award, number of shares authorized		643,797
Plan terminate term		The 12 Plan will terminate no later than November 7, 2022.
Share-based compensation arrangement by share-based payment award, number of shares available for grant		411,593
2012 Equity Incentive Plan [Member] | Non Qualified Stock Options [Member] | Minimum [Member]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent		100.00%
2012 Equity Incentive Plan [Member] | Incentive Stock Options [Member] | Minimum [Member]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent		10.00%
2012 Equity Incentive Plan [Member] | Incentive Stock Options [Member] | Minimum [Member] | If Recipient Owns Greater Than Ten Percent Voting Power [Member]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent		110.00%
2012 Equity Incentive Plan [Member] | Restricted Stock [Member] | Minimum [Member]
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent		100.00%

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Options Outstanding, Beginning Balance	106,077	117,675
Options Outstanding, Granted
Options Outstanding, Forfeited/cancelled	(13,001)	(11,598)
Options Outstanding, Exercised
Options Outstanding, Ending Balance	93,076	106,077
Options Outstanding, Vested and expected to vest at June 30, 2020	93,076
Options Exercisable at December 31, 2020	93,076
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 2.77	$ 2.57
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Forfeited/cancelled
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Outstanding Ending Balance	3.03	$ 2.77
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020	3.03
Weighted Average Exercise Price, Exercisable at December 31, 2020	$ 3.03
Weighted Average Remaining Contractual Life (Years) Outstanding, Beginning Balance	1 year 6 months 10 days	2 years 3 months 11 days
Weighted Average Remaining Contractual Life (Years) Outstanding, Ending Balance	8 months 26 days	1 year 6 months 10 days
Weighted Average Remaining Contractual Life (Years), Vested and expected to vest at December 31, 2020	8 months 26 days
Weighted Average Remaining Contractual Life (Years) Exercisable at December 31, 2020	8 months 26 days

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Share-based Compensation, Shares Authorized Under Stock Option Plans, by Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding, Number of shares | shares	93,076
Options Exercisable, Number of shares | shares	93,076
Exercise Price Range 1 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	$ 0.75
Exercise Price Range, Upper Range Limit	$ 1
Options Outstanding, Number of shares | shares	14,526
Options Outstanding, Weighted Average Remaining Life (Years)	11 days
Options Outstanding, Weighted Average Exercise Price	$ 0.75
Options Exercisable, Number of shares | shares	14,526
Options Exercisable, Weighted Average Exercise Price	$ 0.75
Exercise Price Range 2 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	1.79
Exercise Price Range, Upper Range Limit	$ 4
Options Outstanding, Number of shares | shares	63,684
Options Outstanding, Weighted Average Remaining Life (Years)	10 months 14 days
Options Outstanding, Weighted Average Exercise Price	$ 3.21
Options Exercisable, Number of shares | shares	63,684
Options Exercisable, Weighted Average Exercise Price	$ 3.21
Exercise Price Range 3 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	4.20
Exercise Price Range, Upper Range Limit	$ 6.68
Options Outstanding, Number of shares | shares	14,866
Options Outstanding, Weighted Average Remaining Life (Years)	10 months 21 days
Options Outstanding, Weighted Average Exercise Price	$ 4.46
Options Exercisable, Number of shares | shares	14,866
Options Exercisable, Weighted Average Exercise Price	$ 4.46

Stockholders' Equity - Schedu_3

Stockholders' Equity - Schedule of Warrants Outstanding (Details) - Warrant [Member] - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Warrants Outstanding, beginning balance	481,335	622,912
Warrants Outstanding, Granted
Warrants Outstanding, Forfeited/cancelled		(111,111)
Warrants Outstanding, Exercised	(233,119)	(30,466)
Warrants Outstanding, ending balance	248,216	481,335

Sales by Geographical Locatio_2

Sales by Geographical Location - Schedule of Revenue by Country (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue by country	$ 3,644,000	$ 3,530,100
United States [Member]
Revenue by country	1,276,700	1,133,400
Brazil [Member]
Revenue by country	1,117,300	580,800
Japan [Member]
Revenue by country	338,300	410,000
The Netherlands [Member]
Revenue by country	307,700	445,100
Other Countries [Member]
Revenue by country	$ 604,000	$ 960,800

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Note 10 - Income Taxes (Details) [Line Items]
Federal income tax rate	21.00%	21.00%
Valuation allowance, deferred tax asset, increase (decrease), amount	$ 2,755,000	$ 276,000
Percentage of cumulative ownership	50.00%
Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]
Note 10 - Income Taxes (Details) [Line Items]
Operating loss expiration date	Expire in 2018
Tax credit carryforward, amount	$ 1,000,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Note 10 - Income Taxes (Details) [Line Items]
Operating loss carryforwards	$ 50,300,000
Operating loss expiration date	Expire in 2021
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member]
Note 10 - Income Taxes (Details) [Line Items]
Operating loss carryforwards	$ 6,800,000
Operating loss expiration date	Expire in 2028

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal
State
Foreign
Current income tax expense
Federal
State
Foreign
Deferred income tax expense
Provision (benefit) for income tax

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal income tax (benefit) at statutory rate	$ 145,700	$ 116,400
State income tax (benefit) at statutory rate	16,400	13,900
SBC - NQ cancellations	(2,700)	(2,700)
Change in valuation allowance	(2,763,100)	(284,900)
Meals and entertainment (50%)	200	1,000
Adjustments and NOL expirations	2,603,500	103,400
Contributed services		52,900
Other items
Provision (benefit) for income tax

Income Taxes - Schedule of Ef_2

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Meals and entertainment, percent	50.00%	50.00%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 11,031,900	$ 13,702,300
Tax credit carryforwards	977,500	977,500
Compensation expense - non-qualified stock options	65,800	69,000
Deferred revenue and maintenance service contracts	343,100	419,800
Depreciation, amortization, and capitalized software
Reserves and other	53,300	58,200
Total deferred tax assets	12,471,600	15,226,800
Deferred tax liability - depreciation, amortization and capitalized software
Net deferred tax asset	12,471,600	15,226,800
Valuation allowance	(12,471,600)	(15,226,800)
Net deferred tax asset

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Rent expense	$ 48,000	$ 48,000
Profit sharing plans	16,000	$ 14,100
Concord, NH Headquarters [Member]
Rent expense	$ 4,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Dec. 31, 2020	Jan. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Contributed services			$ 112,400	$ 225,100
Proceeds from offering			2,600,000
Jonathon R. Skeels [Member]
Base salary	$ 200,000
Backstop Agreement [Member]
Number of restricted shares of common stock, value			$ 2,120,000
Number of restricted shares of common stock			7,000,000
Backstop Agreement [Member] | Accredited Investors [Member] | Novelty Capital Partners LP [Member]
Shares issued purchase price, per share		$ 0.30
Backstop Agreement [Member] | Accredited Investors [Member] | Novelty Capital Partners LP [Member] | Maximum [Member]
Number of shares issued in private placement		2,410,000
Backstop Agreement [Member] | Rights Offering [Member] | Novelty Capital Partners LP [Member]
Debt instrument maturity date		Mar. 31, 2020
Rights Offering [Member]
Number of shares issued in private placement			1,600,000
Proceeds from offering			$ 480,200